Ordering
Available Variants1 mg
CHJ.40881-1mg
Price
€575.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHJ.40881-1mg | €575.20 |
≥80%, powder, ≥3,000 W-A units/mg protein
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 9001-03-0 |
|---|---|
| UNSPSC Code | 12352204 |
| NACRES | NA.54 |
| EC Number | 4.2.1.1 (BRENDA, IUBMB) |
| MDL number | MFCD00081467 |
| Specific activity | ≥3,000 W-A units/mg protein |
| Assay | ≥80% |
Safety Information Handling visibility
| pictograms |
GHS08
 GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H334 |
| pcodes | P261 - P284 - P501 |
| Hazard Classifications | Resp. Sens. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Carbonic Anhydrase Isozyme II is a human enzyme with the CAS registry number 9001-03-0, playing a crucial role in the regulation of acid-base balance in the body. This isozyme is one of the most abundant and widely distributed forms of carbonic anhydrase, found in various tissues including red blood cells, kidneys, and the gastrointestinal tract. It catalyzes the reversible hydration of carbon dioxide to form bicarbonate and a proton, facilitating the removal of carbon dioxide from the body and maintaining proper pH levels. The enzymes activity is essential for various physiological processes, including respiration, bone resorption, and the secretion of gastric acid. Its inhibition has been explored as a potential therapeutic strategy for the treatment of various diseases, including glaucoma, epilepsy, and cancer, highlighting the importance of understanding the structure and function of Carbonic Anhydrase Isozyme II.
